Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health. 

Guests:

Dr. Frank Wiegand, Chief Medical Officer, Beckley Psytech

Kurt Rasmussen, Ph.D., Chief Scientific Officer, Delix Therapeutics

Clara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures